Therapeutic Targets in Chronic Lymphocytic Leukemia

被引:3
|
作者
Laurenti, Luca [1 ]
Efremov, Dimitar G. [2 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Hematol, I-00168 Rome, Italy
[2] Int Ctr Genet Engn & Biotechnol, Mol Hematol, I-34149 Trieste, Italy
关键词
IBRUTINIB RESISTANCE; CLONAL EVOLUTION; DE-NOVO; VENETOCLAX; CLL; DISEASE; BTK; INHIBITION;
D O I
10.3390/cancers12113259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Venetoclax for the treatment of chronic lymphocytic leukemia
    Gentile, Massimo
    Petrungaro, Annamaria
    Uccello, Giuseppina
    Vigna, Ernesto
    Recchia, Anna Grazia
    Caruso, Nadia
    Bossio, Sabrina
    De Stefano, Laura
    Palummo, Angela
    Storino, Francesca
    Martino, Massimo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1307 - 1316
  • [42] Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
    Herbert Eradat
    Current Hematologic Malignancy Reports, 2019, 14 : 469 - 476
  • [43] Clonal dynamics in chronic lymphocytic leukemia
    Gutierrez, Catherine
    Wu, Catherine J.
    BLOOD ADVANCES, 2019, 3 (22) : 3759 - 3769
  • [44] Zanubrutinib for the treatment of chronic lymphocytic leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (13) : 1409 - 1413
  • [45] Chronic lymphocytic Leukemia
    Bergmann, Manuela
    Wendtner, Clemens-Martin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (07) : 479 - 482
  • [46] Frontline therapy in Chronic Lymphocytic Leukemia
    Arguello-Tomas, Miguel
    Albiol, Nil
    Moreno, Carol
    ACTA HAEMATOLOGICA, 2024, 147 (01) : 49 - 61
  • [47] Importance of genetics in chronic lymphocytic leukemia
    Zenz, Thorsten
    Mertens, Daniel
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD REVIEWS, 2011, 25 (03) : 131 - 137
  • [48] Chronic lymphocytic leukemia
    Hallek, Michael
    Pflug, Natali
    ANNALS OF ONCOLOGY, 2010, 21 : 154 - 164
  • [49] Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia
    Hampel, Paul J.
    Parikh, Sameer A.
    Call, Timothy G.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1289 - 1301
  • [50] Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
    Delgado, Julio
    Nadeu, Ferran
    Colomer, Dolors
    Campo, Elias
    HAEMATOLOGICA, 2020, 105 (09) : 2205 - 2217